Emma Logan
Impact in
-
- CAR-T cell therapy research
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 2
- Multiple Myeloma Research and Treatments 2
- Oncology 6
- CAR-T cell therapy research 6
- Co-authors
- David Avigan (7 shared papers)Matthew J. Frigault (4 shared papers)Jacalyn Rosenblatt (7 shared papers)Andrzej Jakubowiak (2 shared papers)Sarah Nikiforow (3 shared papers)Michael R. Bishop (3 shared papers)Kit L. Shaw (1 shared paper)Daniella Cook (3 shared papers)
- Journals
- Blood (6 papers)Journal of Clinical Oncology (2 papers)Leukemia Research (1 paper)Blood Advances (1 paper)Open Forum Infectious Diseases (1 paper)
- Partner nations
- United States
In The Last Decade
Emma Logan
10 papers receiving 72 citations
Peers
Comparison fields: 5 of 19
- Oncology 62
- Hematology 25
- Immunology 15
- Molecular Biology 37
- Biomedical Engineering 21
Countries citing papers authored by Emma Logan
This map shows the geographic impact of Emma Logan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Logan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Logan more than expected).
Fields of papers citing papers by Emma Logan
This network shows the impact of papers produced by Emma Logan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Logan. The network helps show where Emma Logan may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Logan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 50 | |
| 2 | 2022 | 6 | |
| 3 | 2021 | 6 | |
| 4 | 2016 | 4 | |
| 5 | 2022 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2025 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2019 | 1 | |
| 10 | 2021 | 1 | |
| 11 | 2024 | 0 |
About Emma Logan
Emma Logan is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Genetics, having authored 11 papers that have together received 75 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Acute Myeloid Leukemia Research (3 papers), Protein Degradation and Inhibitors (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Multiple Myeloma Research and Treatments (2 papers), Lymphoma Diagnosis and Treatment (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (62 citations), Hematology (25 citations), Immunology (15 citations), Molecular Biology (37 citations) and Biomedical Engineering (21 citations). Emma Logan has collaborated with scholars based in United States. Frequent co-authors include David Avigan, Matthew J. Frigault, Jacalyn Rosenblatt, Andrzej Jakubowiak, Sarah Nikiforow, Michael R. Bishop, Kit L. Shaw, Daniella Cook, Elizabeth O’Donnell and Noopur Raje. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Blood Advances and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.